Miami Herald: Insulin company offers free 90-day supply amid coronavirus pandemic. Who qualifies?. “An insulin company is offering a free 90-day supply to people with diabetes who’ve been financially affected by the coronavirus pandemic. People who use Novo Nordisk insulin who have lost health insurance coverage during the pandemic may be eligible for the company’s Diabetes Patient Assistance Program, according to a news release.”
OneZero: A Black Market for Life-Saving Insulin Thrives on Social Media. “Insulin is an essential and life-saving drug used by 7.4 million people in the United States. Over the last few years, it’s become increasingly expensive. Between 2012 and 2016, the price of insulin effectively doubled for people with type one diabetes, with costs jumping from $239 to $475 per month, on average. These controversial and dramatic price hikes, singled out by presidential candidates like Bernie Sanders and Elizabeth Warren, have become symbols of a failing American healthcare system. They have also created a thriving online black market for insulin.”
Techdirt: Abbott Laboratories Sends Heavy-Handed Copyright Threat To Shut Down Diabetes Community Tool For Accessing Blood-Sugar Data. “A few months back there was a post on Diabettech about some code posted to GitHub. A patch to Abbott Laboratories’ LibreLink app allowed data from the same company’s FreeStyle Libre continuous monitor to be accessed by other apps running on a smartphone. In particular, it enabled the blood-sugar data to be used by a program called xDrip, which provides ‘sophisticated charting, customization and data entry features as well as a predictive simulation model.’ Innocent enough, you might think. But not according to Abbott Laboratories, which sent in the legal heavies waving the DMCA.” Heaven forbid people get as much access to and use of their own personal medical information as possible. Pllbbt.